Difference between revisions of "Project:Background"

From Psychiatrienet
Jump to: navigation, search
(Editor-in-chief)
(Acknowledgements)
(23 intermediate revisions by 3 users not shown)
Line 6: Line 6:
  
 
===Editor-in-chief===  
 
===Editor-in-chief===  
'''Walter Broekema (1953) is the founder and editor-in-chief of this WIKI'''.  
+
'''Asmar Al Hadithy (PhD PharmD) is the current editor-in-chief of this WIKI'''.  
[[image:WB paraplu.JPG|left|135px|Walter Broekema]]
+
 
He is now freelance hospital pharmacist. He was head of the clinical pharmacy department at [http://www.ggzcentraal.nl GGz Centraal] in Amersfoort, The Netherlands. He had also has pharmaceutical responsibility for a number of other Mental Health Institutions. He graduated as a pharmacist in 1979 and gained his specialisation `hospital pharmacist' in 1991. He has worked at university and community pharmacy. He is active in several organisations inside and outside the hospital, nationally and internationally. He is president of the Special Interest Group Psychiatry of the Dutch Association of Hospital Pharmacists (NVZA/KNMP). He initiated the ATC-drug-distribution robot, started an early audiovisual quality manual and is active in several E-projects like this one. One of his favourites is multidisciplinary cooperation and education. He actively participates in (inter)national conferences.  <br />Conflict of interests: no pharmaceutical companies nor financial interest is involved. Declared 2015. 
+
He is now chief hospital pharmacist and head of the clinical pharmacy department of Parnassia Psychiatry Institute. <br clear="all">
<br clear="all">
+
 
 +
[[image:Logo_apotheek_klein.jpg|left|135px|Parnassia Group Pharmacy]]
 +
 
 +
 
 +
 
 +
 
  
 
===Acknowledgements===
 
===Acknowledgements===
 +
* ''' Walter Broekema,MSc, PharmD''': founder and past-editor-in-chief (2008-2018)
 
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines
 
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines
* ''' Roland van den Berg, BSc, coming up: MSc, PharmD''': maintenance, new drugs
+
* ''' Sietske Brouwer, MSc, PharmD''': maintenance
* ''' Sietske Brouwer, BSc, coming up: MSc, PharmD''': maintenance
 
 
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions
 
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions
 
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers
 
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers
* ''' Hélène Lichtenberg,MSc, PharmD''': hypericum switches
+
* ''' Hélène Lichtenberg, MSc, PharmD''': hypericum switches
 
* ''' Ashni Lo-Kim-Lin, MSc, PharmD''': general
 
* ''' Ashni Lo-Kim-Lin, MSc, PharmD''': general
 
* ''' Lenneke Minjon, MSc, PharmD''': plain stopping antidepressants
 
* ''' Lenneke Minjon, MSc, PharmD''': plain stopping antidepressants
Line 26: Line 31:
 
* ''' Arend Veeninga †, psychiatrist, PhD''': tester user interface
 
* ''' Arend Veeninga †, psychiatrist, PhD''': tester user interface
 
* ''' Mathilde van Veggel, MSc, PharmD''': maintenance
 
* ''' Mathilde van Veggel, MSc, PharmD''': maintenance
 +
* ''' Anoek Verbeij, Bsc ''': maintenance
  
 
=== Work in progress ===
 
=== Work in progress ===

Revision as of 13:35, 26 October 2018

More information and/or sources of switching antidepressants and antipsychotics

Mission statement

To improve independently psychopharmacotherapy and medication safety for all patients.

Editor-in-chief

Asmar Al Hadithy (PhD PharmD) is the current editor-in-chief of this WIKI.

He is now chief hospital pharmacist and head of the clinical pharmacy department of Parnassia Psychiatry Institute.

Parnassia Group Pharmacy



Acknowledgements

  • Walter Broekema,MSc, PharmD: founder and past-editor-in-chief (2008-2018)
  • Ralph de Backer, MSc, PharmD: benzodiazepines
  • Sietske Brouwer, MSc, PharmD: maintenance
  • Jaap Kerkvliet, MSc, PharmD: flagged revisions
  • Klaas Kooistra, MSc, PharmD: moodstabilizers
  • Hélène Lichtenberg, MSc, PharmD: hypericum switches
  • Ashni Lo-Kim-Lin, MSc, PharmD: general
  • Lenneke Minjon, MSc, PharmD: plain stopping antidepressants
  • Alexandra Mulder, MSc, PharmD: antidepressants
  • Verena Mulder, MSc, PharmD: antipsychotics
  • Mariska de Roo, PharmD: general & authorization
  • Arent Storm, MSc: website design & realization, technical and methodological supervision, benzo convertor
  • Arend Veeninga †, psychiatrist, PhD: tester user interface
  • Mathilde van Veggel, MSc, PharmD: maintenance
  • Anoek Verbeij, Bsc : maintenance

Work in progress

We are gradually improving the tables by adding more references, graphics etc. This will take time.